New Vitalis Pharmacy has recalled approximately 2,982 units of Testosterone Cypionate/Testosterone Propionate Oil Injection Solution because the pharmacy cannot guarantee the products are sterile. Using an injectable medication that is not sterile can lead to serious and potentially life-threatening infections. The affected products were distributed nationwide in 10 mL vials and include various lot numbers with expiration dates ranging from September 2019 through November 2019. If you have this medication, you should immediately contact your doctor or pharmacist to discuss your treatment options and how to safely return the product.
A lack of sterility assurance means the injectable drug may contain bacteria, fungi, or other contaminants. Injecting a non-sterile product directly into the body can cause localized infections at the injection site or systemic infections that can lead to severe illness or death.
Healthcare provider consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.